Stock listing
Lang & Schwarz:A3EHM3 Verastem, Inc. Aktie
German listing (Lang & Schwarz) of Verastem, Inc. · home listing NASDAQ:VSTM
Follow Verastem, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:VSTM
$9.75 USD +0.09 (+0.9%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:VSTM
- Day range
- $9.50 – $9.92 USDOct 30, 2026
- Volume
- 2.41M sharesOct 30, 2026
- Market cap
- $1.18B USDAt the close on Oct 30, 2026 · price × 121.5M shares outstanding
- 52-week range
- $3.43 – $10.82 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $26.21M USDMedian day 2.30M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:VSTM · Home | $9.75 USD | +0.09 (+0.9%) | 2,409,918 | $9.63 | $9.92 | $9.50 | $9.66 | Close on Oct 30, 2026 |
| LSE:0LOV | $10.05 USD | +0.238 (+2.4%) | 3,559 | $9.78 | $10.10 | $9.78 | $9.812 | Close on Oct 27, 2026 |
| Frankfurt:2VSA | €8.40 EUR | +0.056 (+0.7%) | — | €8.208 | €8.43 | €8.208 | €8.344 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:VSTM · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $9.75 | +0.09 | +0.9% | $9.63 | $9.92 | $9.50 | 2,409,918 | |
| $9.66 | -0.175 | -1.8% | $9.85 | $10.03 | $9.54 | 1,939,431 | |
| $9.835 | -0.265 | -2.6% | $10.08 | $10.25 | $9.78 | 2,805,639 | |
| $10.10 | +0.10 | +1.0% | $9.95 | $10.15 | $9.76 | 4,704,743 | |
| $10.00 | -0.04 | -0.4% | $10.00 | $10.16 | $9.345 | 4,289,051 | |
| $10.04 | -0.02 | -0.2% | $10.09 | $10.22 | $9.71 | 3,762,000 | |
| $10.06 | +0.85 | +9.2% | $9.20 | $10.11 | $9.14 | 5,947,100 | |
| $9.21 | -0.13 | -1.4% | $9.41 | $9.67 | $9.12 | 3,061,500 | |
| $9.34 | +0.72 | +8.4% | $8.62 | $9.47 | $8.57 | 3,961,800 | |
| $8.62 | -0.03 | -0.3% | $8.58 | $9.17 | $8.51 | 3,397,000 | |
| $8.65 | -0.58 | -6.3% | $9.24 | $9.37 | $8.53 | 6,090,700 | |
| $9.23 | +1.52 | +19.7% | $8.04 | $9.73 | $7.77 | 16,959,000 | |
| $7.71 | +0.26 | +3.5% | $8.00 | $8.96 | $6.70 | 33,754,300 | |
| $7.45 | -0.80 | -9.7% | $8.15 | $8.20 | $7.45 | 3,429,200 | |
| $8.25 | -0.13 | -1.6% | $8.42 | $8.60 | $8.08 | 3,582,200 | |
| $8.38 | +0.27 | +3.3% | $8.12 | $8.58 | $7.98 | 2,970,000 | |
| $8.11 | -0.16 | -1.9% | $8.20 | $8.28 | $7.72 | 3,051,500 | |
| $8.27 | +0.52 | +6.7% | $7.77 | $8.36 | $7.65 | 3,928,400 | |
| $7.75 | -0.25 | -3.1% | $8.08 | $8.18 | $7.70 | 2,512,300 | |
| $8.00 | +0.30 | +3.9% | $7.74 | $8.10 | $7.52 | 2,216,400 | |
| $7.70 | -0.20 | -2.5% | $7.95 | $8.02 | $7.52 | 4,071,700 | |
| $7.90 | -0.15 | -1.9% | $8.00 | $8.18 | $7.74 | 1,762,300 | |
| $8.05 | +0.13 | +1.6% | $7.98 | $8.40 | $7.92 | 1,568,500 | |
| $7.92 | +0.15 | +1.9% | $7.78 | $8.12 | $7.56 | 2,677,100 | |
| $7.77 | +0.03 | +0.4% | $7.59 | $7.78 | $7.39 | 1,260,500 | |
| $7.74 | -0.06 | -0.8% | $7.86 | $7.89 | $7.67 | 1,060,000 | |
| $7.80 | -0.38 | -4.6% | $8.10 | $8.20 | $7.71 | 1,844,600 | |
| $8.18 | -0.19 | -2.3% | $8.37 | $8.40 | $7.85 | 1,935,600 | |
| $8.37 | +0.38 | +4.8% | $8.04 | $8.65 | $8.00 | 3,056,000 | |
| $7.99 | +0.55 | +7.4% | $7.54 | $8.04 | $7.50 | 2,800,200 | |
| $7.44 | -0.11 | -1.5% | $7.58 | $7.84 | $7.40 | 4,496,800 | |
| $7.55 | +0.23 | +3.1% | $7.58 | $7.91 | $7.54 | 1,734,200 | |
| $7.32 | -0.02 | -0.3% | $7.35 | $7.41 | $7.20 | 1,449,300 | |
| $7.34 | -0.17 | -2.3% | $7.48 | $7.52 | $7.25 | 2,839,800 | |
| $7.51 | +0.19 | +2.6% | $7.36 | $7.62 | $7.25 | 1,514,400 | |
| $7.32 | -0.30 | -3.9% | $7.70 | $7.79 | $7.32 | 1,912,900 | |
| $7.62 | -0.32 | -4.0% | $7.91 | $7.91 | $7.45 | 2,670,000 | |
| $7.94 | -0.14 | -1.7% | $8.01 | $8.38 | $7.80 | 2,399,500 | |
| $8.08 | -0.12 | -1.5% | $8.20 | $8.54 | $7.89 | 4,366,300 | |
| $8.20 | +0.22 | +2.8% | $7.91 | $8.21 | $7.72 | 2,301,000 | |
| $7.98 | -0.04 | -0.5% | $8.03 | $8.14 | $7.91 | 2,627,100 | |
| $8.02 | +0.41 | +5.4% | $7.70 | $8.10 | $7.68 | 5,258,900 | |
| $7.61 | +0.39 | +5.4% | $7.19 | $7.64 | $7.13 | 2,078,000 | |
| $7.22 | 0.00 | 0.0% | $7.20 | $7.32 | $7.00 | 1,324,300 | |
| $7.22 | -0.16 | -2.2% | $7.32 | $7.38 | $7.18 | 1,084,400 | |
| $7.38 | -0.01 | -0.1% | $7.38 | $7.57 | $7.31 | 1,300,200 | |
| $7.39 | +0.31 | +4.4% | $7.08 | $7.45 | $6.91 | 1,682,100 | |
| $7.08 | +0.22 | +3.2% | $6.93 | $7.20 | $6.90 | 1,189,200 | |
| $6.86 | -0.03 | -0.4% | $6.90 | $6.96 | $6.62 | 1,166,500 | |
| $6.89 | +0.07 | +1.0% | $6.88 | $7.02 | $6.78 | 995,000 | |
| $6.82 | -0.48 | -6.6% | $7.25 | $7.43 | $6.63 | 2,294,200 | |
| $7.30 | -0.13 | -1.7% | $7.65 | $7.86 | $7.20 | 2,371,600 | |
| $7.43 | +0.25 | +3.5% | $7.18 | $7.68 | $7.18 | 2,924,100 | |
| $7.18 | +0.60 | +9.1% | $6.52 | $7.20 | $6.45 | 2,284,000 | |
| $6.58 | -0.09 | -1.3% | $6.66 | $6.66 | $6.44 | 1,280,100 | |
| $6.67 | -0.28 | -4.0% | $7.06 | $7.06 | $6.64 | 1,856,800 | |
| $6.95 | -0.10 | -1.4% | $7.01 | $7.10 | $6.89 | 1,263,600 | |
| $7.05 | +0.26 | +3.8% | $6.71 | $7.18 | $6.62 | 2,087,700 | |
| $6.79 | +0.05 | +0.7% | $6.67 | $6.84 | $6.34 | 2,298,100 | |
| $6.74 | +0.83 | +14.0% | $6.65 | $7.10 | $6.02 | 4,319,000 | |
| $5.91 | +0.04 | +0.7% | $5.91 | $6.00 | $5.73 | 2,189,500 | |
| $5.87 | +0.06 | +1.0% | $5.88 | $5.97 | $5.78 | 1,555,000 | |
| $5.81 | +0.12 | +2.1% | $5.64 | $5.89 | $5.64 | 1,791,700 | |
| $5.69 | -0.11 | -1.9% | $5.81 | $5.85 | $5.58 | 1,288,100 | |
| $5.80 | -0.30 | -4.9% | $6.04 | $6.09 | $5.54 | 1,857,200 | |
| $6.10 | +0.09 | +1.5% | $5.92 | $6.17 | $5.71 | 1,451,500 |
- Ticker
- Lang & Schwarz:A3EHM3
- Asset type
- Stock
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Oct 22, 2026
Verastem Oncology to Report Third Quarter 2026 Financial Results on November 5, 2026
Latest earnings call · Aug 6, 2026
Verastem (NASDAQ:VSTM) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Oct 14, 2026
Technical Presentation (October 2026)
Technical · 60 slides
Calls
Upcoming
Verastem (NASDAQ:VSTM) Q3 2026 Earnings Call
Thu, Nov 05, 2026 · 4:30 PM ET
Register
Replays
Verastem (NASDAQ:VSTM) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 4:30 PM ET
Watch TranscriptVerastem (NASDAQ:VSTM) Q1 2026 Earnings Call
Thu, May 07, 2026 · 4:30 PM ET
Watch TranscriptVerastem (NASDAQ:VSTM) Q4 2025 Earnings Call
Wed, Mar 04, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Verastem Oncology to Report Third Quarter 2026 Financial Results on November 5, 2026
Oct 22, 2026
Closed $10.06 (+9.2%) on Oct 22, 2026
Verastem Oncology Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants
Oct 14, 2026
Closed $7.71 (+3.5%) on Oct 14, 2026
Verastem Oncology Announces Planned Chief Executive Officer Transition and Succession Plan
Oct 14, 2026
Closed $7.71 (+3.5%) on Oct 14, 2026
VS-7375 Demonstrates Robust Anti-Tumor Activity Across Advanced KRAS G12D-Mutant Cancers, Highlighted by 50% Confirmed ORR in 2L Pancreatic Ductal Adenocarcinoma and Two Complete Responses in 2L+ Disease (One Confirmed)
Oct 14, 2026
Closed $7.71 (+3.5%) on Oct 14, 2026
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 5, 2026
Closed $7.75 (-3.1%) on Oct 6, 2026
Verastem Oncology Announces New RAMP 201 Molecular Profiling and External Control Arm Analyses Describing Outcomes for Avutometinib Plus Defactinib in Recurrent Low-Grade Serous Ovarian Cancer to be Presented at IGCS 2026
Oct 2, 2026
Closed $7.70 (-2.5%) on Oct 2, 2026
Verastem Oncology Announces Publication in Gynecologic Oncology of Two-Year Median Follow-Up Data from RAMP 201 Study of AVMAPKI® FAKZYNJA® CO-PACK (avutometinib capsules; defactinib tablets) in Recurrent Low-Grade Serous Ovarian Cancer
Sep 28, 2026
Closed $7.92 (+1.9%) on Sep 29, 2026
Verastem Oncology Announces Late-Breaking Oral Presentation of RAMP 201 Low-Grade Serous Ovarian Cancer Molecular Profiling and Tumor Biomarker Analysis at IGCS 2026 Annual Global Meeting
Sep 24, 2026
Closed $7.80 (-4.6%) on Sep 24, 2026
Verastem Oncology to Unveil New Clinical Data Highlighting the Best-in-Class Potential of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, Across Pancreatic, Lung, and Colorectal Cancers
Sep 8, 2026
Closed $8.08 (-1.5%) on Sep 8, 2026
Verastem Oncology to Participate in Upcoming September Investor Conferences
Sep 2, 2026
Closed $8.02 (+5.4%) on Sep 2, 2026
Financings
Public offering of common stock and pre-funded warrants
Oct 14, 2026
Announced: about US$250M · US$8 a share · Jefferies +3
Dealers: Jefferies (co-lead), Guggenheim Securities (co-lead), Cantor (co-lead), B. Riley Securities
Use of proceeds: Clinical development of product candidates including the VS-7375 program, working capital and general corporate purposes
Decks
Technical Presentation (October 2026)
Technical · 60 slides · Oct 14, 2026
IGCS 2026
Conference · 7 slides · Oct 2, 2026
Q2 2026 Earnings Presentation
Earnings · 13 slides · Aug 6, 2026
Investor Presentation (August 2026)
Investor deck · 49 slides · August 2026
Verastem, Inc. on 6ix
- News releases
- 40 in the last 12 months · 185 in all · newest Oct 22, 2026 · oldest 2019
- Calls
- 5 calls with a replay · 5 with a transcript · latest Aug 6, 2026
- Decks
- 55 decks · latest Oct 14, 2026
Where Verastem, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:VSTM · Home listing | NASDAQ | United States | USD |
| LS Exchange:A3EHM3 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A3EHM3 · This page | Lang & Schwarz | Germany | EUR |
| gettex:2VSA | gettex | Germany | EUR |
| BOATS:VSTM | BOATS | United States | USD |
| LSE:0LOV | LSE | United Kingdom | USD |
| Dusseldorf:2VSA | Dusseldorf | Germany | EUR |
| Frankfurt:2VSA | Frankfurt | Germany | EUR |
| Hamburg:2VSA | Hamburg | Germany | EUR |
| Munich:2VSA | Munich | Germany | EUR |
| Stuttgart:2VSA | Stuttgart | Germany | EUR |
| Tradegate:2VSA | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Verastem, Inc.